News
A patient on the Monjuvi trial saw lymph nodes shrink 85%, with stable results a year later, supporting the FDA’s recent ...
Hodgkin's lymphoma market size is expected to increase during the forecast period (2025–2034) owing to increasing incidence, advancements in ...
Hosted on MSN15d
9 common causes of armpit pain, according to doctors - MSNFrom muscle strains, bacterial and viral infections, and skin rashes, here are 9 possible causes of armpit pain and when to see a doctor.
Coconino County Health and Human Services recently received a report of a prairie dog die-off on private land northeast of Flagstaff.
Hosted on MSN23d
Are itchy armpits a sign of cancer? Read here - MSNItchy armpits are often caused by non-cancerous conditions, such as poor hygiene or dermatitis. However, in some cases, the itch may be a sign of more serious conditions, like lymphoma or ...
15d
azcentral.com on MSNPrairie dogs dying in northern Arizona; Officials are concerned it's the plagueCoconino County Health and Human Services recently received a report of a prairie dog die-off on private land northeast of ...
It has since been confirmed that the patient’s death was caused by pneumonic plague, which is a severe lung infection caused ...
11h
WRIC ABC 8News on MSNVCU Massey Comprehensive Cancer Center enrolls patients in global trial of T-cell lymphomaMassey Comprehensive Cancer Center is the first U.S. site to enroll patients in a global trial of first-in-class therapy for ...
17h
Health on MSNWhy Do My Armpits Sweat So Much? Learn Why and How to Fix ItExcessive armpit sweating can happen for many reasons, including heat and humidity, stress, consuming certain drinks and ...
Explore the latest advancements in immunotherapies for T-cell lymphoma, addressing unique challenges and promising new ...
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Mantle cell lymphoma treatment offers options if patients relapse after CAR T-cell therapy, from bispecific antibodies, antibody drug conjugates, and other emerging therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results